Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: exemestane|DRUG: Placebo
Sponsor: NSABP Foundation Inc
Collaborators: National Cancer Institute (NCI)